BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14530164)

  • 21. Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice.
    Zips D; Hessel F; Krause M; Schiefer Y; Hoinkis C; Thames HD; Haberey M; Baumann M
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):908-14. PubMed ID: 15708274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules.
    Appold S; Baumann M; Petersen C; Horn K; Eichhorn F
    Strahlenther Onkol; 1998 Jun; 174(6):315-9. PubMed ID: 9645213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of changing the weekly dose intensity of fractionated irradiation on local control of two human squamous cell carcinomas in nude mice.
    Petersen C; Schreiber A; Maiwald C; Arps H; Baumann M
    Int J Radiat Biol; 2000 Oct; 76(10):1349-56. PubMed ID: 11057743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation.
    Baumann M; Petersen C; Schulz P; Baisch H
    Radiother Oncol; 1999 Jan; 50(1):107-11. PubMed ID: 10225564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
    Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma.
    Budach W; Paulsen F; Welz S; Classen J; Scheithauer H; Marini P; Belka C; Bamberg M
    Br J Cancer; 2002 Feb; 86(3):470-6. PubMed ID: 11875717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of preirradiation of the tumour bed on cell production rate and cell loss of human FaDu squamous cell carcinoma growing in nude mice.
    Petersen C; Eicheler W; Baisch H; Zips D; Baumann M
    Int J Radiat Biol; 1999 Oct; 75(10):1293-7. PubMed ID: 10549606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas.
    Zips D; Le K; Yaromina A; Dörfler A; Eicheler W; Zhou X; Geyer P; Hilberg F; Baumann M
    Radiother Oncol; 2009 Sep; 92(3):405-10. PubMed ID: 19409639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units.
    Baumann M; Dubois W; Suit HD
    Radiat Res; 1990 Sep; 123(3):325-30. PubMed ID: 2145606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cetuximab and fractionated irradiation on tumour micro-environment.
    Santiago A; Eicheler W; Bussink J; Rijken P; Yaromina A; Beuthien-Baumann B; van der Kogel AJ; Baumann M; Krause M
    Radiother Oncol; 2010 Nov; 97(2):322-9. PubMed ID: 20667608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Time factor and repopulation during fractionated radiotherapy. Comparison between two xenografted human squamous cell carcinoma].
    Hesselmann S; Lindel K; Horn K; Könemann S; Schuck A; Willich N; Rübe C
    Strahlenther Onkol; 2003 Jan; 179(1):38-44. PubMed ID: 12540983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
    Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
    Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor.
    Solomon B; Hagekyriakou J; Trivett MK; Stacker SA; McArthur GA; Cullinane C
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):713-23. PubMed ID: 12573759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamous cell carcinoma in nude mice.
    Baumann M; Petersen C; Wolf J; Schreiber A; Zips D
    Radiother Oncol; 2001 May; 59(2):187-94. PubMed ID: 11325448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.
    Baumann M; Appold S; Zimmer J; Scharf M; Beuthien-Baumann B; Dubben HH; Enghardt W; Schreiber A; Eicheler W; Petersen C
    Acta Oncol; 2001; 40(4):519-28. PubMed ID: 11504313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation.
    Zips D; Krause M; Hessel F; Westphal J; Brüchner K; Eicheler W; Dörfler A; Grenman R; Petersen C; Haberey M; Baumann M
    Anticancer Res; 2003; 23(5A):3869-76. PubMed ID: 14666690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.
    Suit HD; Zietman A; Tomkinson K; Ramsay J; Gerweck L; Sedlacek R
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):365-73. PubMed ID: 2154419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
    Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.